These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3436673)

  • 1. Penetration of fosfomycin into cerebrospinal fluid across non-inflamed and inflamed meninges.
    Kühnen E; Pfeifer G; Frenkel C
    Infection; 1987; 15(6):422-4. PubMed ID: 3436673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid penetration of cefpirome in patients with non-inflamed meninges.
    Nix DE; Wilton JH; Velasquez N; Budny JL; Lassman HB; Mitchell P; Divan K; Schentag JJ
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():51-7. PubMed ID: 1601757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges.
    Gogos CA; Maraziotis TG; Papadakis N; Beermann D; Siamplis DK; Bassaris HP
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):511-4. PubMed ID: 1915388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic aspects of cerebrospinal fluid penetration of fosfomycin.
    Pfeifer G; Frenkel C; Entzian W
    Int J Clin Pharmacol Res; 1985; 5(3):171-4. PubMed ID: 4018950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fosfomycin levels in the cerebrospinal fluid of patients with and without meningitis].
    Friedrich H; Engel E; Potel J
    Immun Infekt; 1987 May; 15(3):98-102. PubMed ID: 3610209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges.
    Nau R; Prange HW; Muth P; Mahr G; Menck S; Kolenda H; Sörgel F
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1518-24. PubMed ID: 8363385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meningeal diffusion of cefpirome in adults].
    Chavanet P; Pechinot A; Waldner-Combernoux A; Kazmierczak A; Portier H
    Pathol Biol (Paris); 1989 May; 37(5):442-5. PubMed ID: 2780101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the levels of fosfomycin in the cerebrospinal fluid in adult meningitis.
    Drobnic L; Quiles M; Rodríguez A
    Chemotherapy; 1977; 23 Suppl 1():180-8. PubMed ID: 832513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The passage of fosfomycin into the cerebrospinal fluid in children's meningitis.
    Llorens J; Lobato A; Olay T
    Chemotherapy; 1977; 23 Suppl 1():189-95. PubMed ID: 832514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges.
    Nau R; Prange HW; Menck S; Kolenda H; Visser K; Seydel JK
    J Antimicrob Chemother; 1992 Jun; 29(6):719-24. PubMed ID: 1506352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum and cerebrospinal fluid kinetics of ceftazidime].
    Nadstawek J; Weil HP; Frenkel C; Kühnen E; Mauersberger W; Hörnchen U
    Immun Infekt; 1989 Dec; 17(6):212-6. PubMed ID: 2693344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis.
    Pfausler B; Spiss H; Dittrich P; Zeitlinger M; Schmutzhard E; Joukhadar C
    J Antimicrob Chemother; 2004 May; 53(5):848-52. PubMed ID: 15056646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The penetration of cefuroxime into the cerebrospinal fluid through inflamed and non-inflamed meninges.
    Müller C; Netland A; Dawson AF; Andrew E
    J Antimicrob Chemother; 1980 Mar; 6(2):279-83. PubMed ID: 7380771
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics and cerebrospinal fluid penetration of norvancomycin in Chinese adult patients.
    Li J; He S; Yang Z; Lu C
    Int J Antimicrob Agents; 2017 May; 49(5):603-608. PubMed ID: 28366660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transfer of fosfomycin into the cerebrospinal fluid].
    Ito H; Ikeda K; Kawano H; Kitabayashi M; Maeda M; Ishise J; Futami K; Yamamoto S
    Jpn J Antibiot; 1982 Nov; 35(11):2530-4. PubMed ID: 7169661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis.
    Nau R; Zysk G; Reinert RR; Mergeryan H; Eiffert H; Prange HW
    J Antimicrob Chemother; 1995 Dec; 36(6):997-1004. PubMed ID: 8821598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The penetration of cefmenoxime into cerebrospinal fluid across non-inflamed meninges.
    Rolston KV; Chandrasekar PH; Smith BR; LeFrock JL
    J Antimicrob Chemother; 1983 Nov; 12(5):519-21. PubMed ID: 6323372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diffusion of fosfomycin into the cerebrospinal fluid in purulent meningitis].
    Stahl JP; Croize J; Bru JP; Girard-Blanc MF; François P; Gaillat J; Micoud M
    Presse Med; 1984 Dec; 13(44):2693-5. PubMed ID: 6240034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosfomycin penetration into the cerebrospinal fluid of patients with bacterial meningitis.
    Sicilia T; Estévez E; Rodríguez A
    Chemotherapy; 1981; 27(6):405-13. PubMed ID: 6794992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic profile of fosfomycin trometamol.
    Bergan T; Thorsteinsson SB; Albini E
    Chemotherapy; 1993; 39(5):297-301. PubMed ID: 8370321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.